Corrigendum to “5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications” (5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications (2011) 48(1) (98–105), (S014181301000303X), (10.1016/j.ijbiomac.2010.10.003));5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications

International Journal of Biological Macromolecules

Volumn 48, Issue 1, 2011, Pages 98-105

  Rejinold, N Sanoj ^a   Muthunarayanan, M ^a   Chennazhi, K P ^a   Nair, S V ^a   Jayakumar, R ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer drug delivery; Cellular uptake; Coacervation method; Fibrinogen nanoparticles; Loading efficiency

Indexed keywords

CALCIUM CHLORIDE; FIBRINOGEN NANOPARTICLE; FLUOROURACIL; NANOPARTICLE; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CELL STRAIN L 929; CELL STRAIN MCF 7; COACERVATION; CONTROLLED STUDY; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MOUSE; NONHUMAN; PARTICLE SIZE; PROSTATE CANCER; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 78650236699     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2019.06.073     Document Type: Erratum

References (17)

1. Dejaeghere F., Doelker E., Gurny R. Nanaoparticles, Encyclopedia of Controlled Drug Delivery 1999, Wiley, Hoboken, pp. 641-664.
2. Moghimi S.M., Hunter A.C., Murray J.C. Pharmacol. Rev. 2001, 53:283-318.
3. Muller B.G., Leuenberger H., Kissel T. Pharm. Res. 1996, 13:32-37.
4. Patil G.V. Drug. Dev. Res. 2003, 58:219-247.
5. Michaelis M., Langer K., Arnold S., Doerr H., Kreuter J., Cinatl J. Biochem. Biophy. Res. Commun. 2004, 323:1236-1240.
6. Weber C., Coester C., Kreuter J., Langer K. Int. J. Pharm. 2000, 194:91-102.
7. Merodio M., Arnedo A., Renedo M.J., Irache J.M. Eur. J. Pharm. Sci. 2001, 12:251-259.
8. Merodio M., Irache J.M., Valamanesh F., Mirshahi M. Biomaterials 2002, 23:1587-1594.
9. Lin W., Garnett M.C., Davis S.S., Schacht E., Ferruti P., Illum L. J. Control. Release 2001, 71:117-126.
10. Miyazaki S., Hasiguchi N., Sugiyama M., Takado M., Morimoto Y. Pharm. Soc. Jpn. 1986, 34:1370-1375.
11. Sanoj Rejinold N., Muthunarayanan M., Deepa N., Chennazhi K.P., Nair S.V., Jayakumar R. Int. J. Biol. Macromol. 2010, 47:37-43.
12. Jahanshahi J., Babaei Z. Afr. J. Biotechnol. 2008, 7:4926-4934.
13. Li S., Wang A., Jiang W., Guan Z. BMC Cancer 2008, 8:103.
14. Abdelwahed W., Degobert G., Stainmesse S., Fessi H. Adv. Drug Del. Rev. 2006, 58:1688-1713.
15. Ashish D., Jithin C.M., Nair S.V., Jayakumar R. Carbohydr. Polym. 2010, 79:1073-1079.
16. Cavalu S., Simon V., Banica F., Deleanu C. Rom. J. Biophys. 2007, 4:237-245.
17. N. Sanoj Rejinold, K.P. Chennazhi, H. Tamuara, S.V. Nair, R. Jayakumar, Carbohydr. Polym. (in press), doi:10.1016/j.carbpol.2010.08.052.